跳至主要内容
临床试验/NCT07089797
NCT07089797招募中不适用

Effect of Nurse-supported Mobile App for Self-help Cognitive Behavioral Therapy for Insomnia in Informal Cancer Caregivers: a Randomized Controlled Trial

The University of Hong Kong1 个研究点 分布在 1 个国家目标入组 208 人开始时间: 2025年8月11日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
208
试验地点
1
主要终点
Insomnia severity

研究概览

简要总结

This mixed-methods randomized controlled trial investigates whether a nurse-supported mobile app for self-help cognitive behavioral therapy for insomnia (CBT-I) effectively reduces insomnia severity among informal cancer caregivers, compared to sleep hygiene education.<br><br>

The primary research question is:<br> Does nurse-supported mobile app for self-help CBT-I lower insomnia severity among cancer caregivers compared to sleep hygiene education at post-intervention and 3-month follow-up?<br><br>

A total of 208 participants will:<br>

  1. Be randomly assigned to one of two groups:<br> (i) the nurse-supported mobile app-based self-help CBT-I group, which involves a 6-week CBT-I program delivered via a WeChat mini program along with weekly nurse support sessions (up to 20 minutes each); or<br> (ii) the sleep hygiene education group.<br>
  2. Complete assessments at baseline, post-intervention, and 3-month follow-up to measure changes in insomnia severity (primary outcome). Secondary outcomes include subjective sleep outcomes, psychological well-being, caregiver burden, fatigue, health-related quality of life, and participants' acceptability and satisfaction.<br><br>

As recommended for trials of complex interventions, investigators will conduct a process evaluation in alignment with the Medical Research Council (MRC) guidance. The key functions of the process evaluation include: *(1) implementation, (2) mechanisms of impact, and (3) context.*

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age ≥18 years
  • •Informal caregiver (e.g., family member or a friend) who co-resides with a cancer survivor of any site or stage and provides at least 4 hours of unpaid daily care. If two or more caregivers are available for a cancer survivor, the one providing most of the daily care will be included.
  • •Able to understand the research procedures, and read and communicate in Chinese
  • •Able to use WeChat
  • •Insomnia severity index scores > 7

排除标准

  • •Another sleep disorder (e.g., obstructive sleep apnea, restless leg syndrome, rapid eye movement behavior disorder), besides insomnia, that is not adequately treated
  • •Psychotic disorders (e.g., bipolar disorder, schizophrenia); Suicidal ideation with intent and plan OR attempted suicide within the past 2 months
  • •Currently taking any psychotropic drugs (e.g., antidepressants, anxiolytics, sleep medications)
  • •Unstable or acute medical condition or condition requiring surgery in the next 6 months; Pregnancy; or Epilepsy
  • •Currently participating in any other interventional program
  • •Prior experience with CBT-I
  • •Night, evening, early morning or rotating shift work
  • •Currently caring for a cancer patient receiving hospice care

研究组 & 干预措施

Nurse-Supported Mobile App for Self-Help CBT-I in Cancer Caregivers

Experimental

干预措施: Nurse-Supported Mobile App for Self-Help CBT-I (Behavioral)

Sleep hygiene education

Active Comparator

干预措施: Sleep hygiene education (Behavioral)

结局指标

主要结局

Insomnia severity

时间窗: Baseline to 18 week

Insomnia severity will be assessed by Insomnia Severity Index (ISI). The ISI is a well-validated, 7-item scale designed to assess the severity of insomnia retrospectively over the past 2 weeks. Total scores range from 0 to 28, with higher scores indicating more severe insomnia symptoms.

次要结局

  • Sleep patterns(Baseline to 18 week)
  • Sleep quality(Baseline to 18 week)
  • Caregiver burden(Baseline to 18 week)
  • Depressive symptoms(Baseline to 18 week)
  • Anxiety symptoms(Baseline to 18 week)
  • Fatigue(Baseline to 18 week)
  • Health-related quality of life(Baseline to 18 week)
  • Participants' acceptability and satisfaction(Week 6 to week 18)
  • Adverse events(Baseline to 18 week)
  • Intervention delivery(Six weeks post-randomization)
  • Intervention acceptability(6 weeks post-randomization)
  • Intervention fidelity(6 weeks post-intervention)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yangxi Huang

Principal Investigator

The University of Hong Kong

研究点 (1)

Loading locations...

相似试验